Mind Medicine (MindMed) (MNMD) Competitors $9.88 +0.17 (+1.70%) As of 11:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD vs. MOR, XENE, NAMS, KNSA, VKTX, IMVT, OGN, BHC, CGON, and GMTXShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include MorphoSys (MOR), Xenon Pharmaceuticals (XENE), NewAmsterdam Pharma (NAMS), Kiniksa Pharmaceuticals International (KNSA), Viking Therapeutics (VKTX), Immunovant (IMVT), Organon & Co. (OGN), Bausch Health Cos (BHC), CG Oncology (CGON), and Gemini Therapeutics (GMTX). These companies are all part of the "pharmaceutical products" industry. Mind Medicine (MindMed) vs. Its Competitors MorphoSys Xenon Pharmaceuticals NewAmsterdam Pharma Kiniksa Pharmaceuticals International Viking Therapeutics Immunovant Organon & Co. Bausch Health Cos CG Oncology Gemini Therapeutics MorphoSys (NASDAQ:MOR) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability. Is MOR or MNMD more profitable? Mind Medicine (MindMed) has a net margin of 0.00% compared to MorphoSys' net margin of -226.79%. Mind Medicine (MindMed)'s return on equity of -50.24% beat MorphoSys' return on equity.Company Net Margins Return on Equity Return on Assets MorphoSys-226.79% -694.31% -22.55% Mind Medicine (MindMed) N/A -50.24%-39.41% Do analysts prefer MOR or MNMD? Mind Medicine (MindMed) has a consensus target price of $26.50, indicating a potential upside of 168.35%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts plainly believe Mind Medicine (MindMed) is more favorable than MorphoSys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MorphoSys 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Mind Medicine (MindMed) 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Which has more volatility and risk, MOR or MNMD? MorphoSys has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.48, suggesting that its stock price is 148% more volatile than the S&P 500. Does the media prefer MOR or MNMD? In the previous week, Mind Medicine (MindMed) had 2 more articles in the media than MorphoSys. MarketBeat recorded 2 mentions for Mind Medicine (MindMed) and 0 mentions for MorphoSys. Mind Medicine (MindMed)'s average media sentiment score of 1.71 beat MorphoSys' score of 0.00 indicating that Mind Medicine (MindMed) is being referred to more favorably in the news media. Company Overall Sentiment MorphoSys Neutral Mind Medicine (MindMed) Very Positive Do insiders and institutionals believe in MOR or MNMD? 18.4% of MorphoSys shares are held by institutional investors. Comparatively, 27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 0.1% of MorphoSys shares are held by company insiders. Comparatively, 2.3% of Mind Medicine (MindMed) shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better valuation and earnings, MOR or MNMD? Mind Medicine (MindMed) has lower revenue, but higher earnings than MorphoSys. Mind Medicine (MindMed) is trading at a lower price-to-earnings ratio than MorphoSys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMorphoSys$238.28M11.99-$205.35M-$3.48-5.45Mind Medicine (MindMed)N/AN/A-$108.68M-$1.53-6.45 SummaryMind Medicine (MindMed) beats MorphoSys on 13 of the 16 factors compared between the two stocks. Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ ExchangeMarket Cap$751.39M$3.14B$5.76B$10.26BDividend YieldN/A2.36%5.88%4.63%P/E Ratio-6.4521.2576.5826.64Price / SalesN/A456.90525.00124.82Price / CashN/A45.4037.1760.46Price / Book3.089.7014.156.31Net Income-$108.68M-$53.02M$3.29B$271.01M7 Day Performance5.84%1.64%1.28%2.40%1 Month Performance2.76%5.25%5.01%6.77%1 Year Performance62.95%9.69%86.96%27.26% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)2.6203 of 5 stars$9.88+1.7%$26.50+168.4%+52.7%$751.39MN/A-6.4540Positive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730XENEXenon Pharmaceuticals2.406 of 5 stars$35.99-0.6%$53.30+48.1%-10.8%$2.78B$9.43M-10.14210Positive NewsNAMSNewAmsterdam Pharma3.0513 of 5 stars$24.12-0.3%$41.55+72.2%+54.8%$2.72B$64.01M-14.894Positive NewsKNSAKiniksa Pharmaceuticals International2.776 of 5 stars$36.56-1.5%$41.17+12.6%+42.2%$2.71B$423.24M914.23220Positive NewsShort Interest ↑VKTXViking Therapeutics4.1799 of 5 stars$24.08-2.9%$87.50+263.4%-64.7%$2.71BN/A-15.7420Positive NewsIMVTImmunovant2.327 of 5 stars$15.53-3.9%$33.60+116.4%-48.0%$2.71BN/A-5.45120Positive NewsOGNOrganon & Co.4.5229 of 5 stars$10.39-2.5%$17.33+66.9%-50.4%$2.70B$6.40B3.864,000Positive NewsBHCBausch Health Cos4.6493 of 5 stars$7.17-1.2%$9.00+25.5%-3.3%$2.66B$9.63B27.5820,700CGONCG Oncology2.4544 of 5 stars$34.60+3.8%$53.91+55.8%-3.4%$2.64B$1.14M-19.5561News CoverageAnalyst ForecastInsider TradeAnalyst RevisionGap UpGMTXGemini TherapeuticsN/A$59.82-0.8%N/A+25.3%$2.59BN/A-59.8230 Related Companies and Tools Related Companies MOR Alternatives XENE Alternatives NAMS Alternatives KNSA Alternatives VKTX Alternatives IMVT Alternatives OGN Alternatives BHC Alternatives CGON Alternatives GMTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MNMD) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNMD Stock Alerts